SCHEMBL16388355

SCHEMBL16388355

FC(F)(F)c1cc(CBr)ccn1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 3/20 0.67
LOX P28300 1/20 0.65
KCNQ2 O43526 1/20 0.48
TYMS P04818 1/20 0.40
NOTUM Q6P988 1/20 0.40
IDO1 P14902 1/20 0.40
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
ADAMTS4 O75173 1/20 0.37
MMP13 P45452 1/20 0.37
AR P10275 1/20 0.36
VNN1 O95497 1/20 0.36
CA2 P00918 1/20 0.35
CHKA P35790 1/20 0.35
GPR52 Q9Y2T5 1/20 0.35
NOS3 P29474 1/20 0.34
NOS2 P35228 1/20 0.34
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30119999 1.00 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL31375482 0.80 LOXL2 (0.49) LOXL2LOXKCNQ2NOTUMIDO1
SCHEMBL8224465 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL131880 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL29988849 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL30885142 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL16047057 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL8256658 0.80 LOXL2 (1.00) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL8180170 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM
SCHEMBL9057494 0.80 LOXL2 (0.67) LOXL2LOXKCNQ2TYMSNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428420-B2 Tricyclic heterocycles as FGFR inhibitors INCYTE CORPORATION (US) 2025-09-30 US disclosed
EP-4352060-A1 TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2024-04-17 EP disclosed
US-20230002384-A1 TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS INCYTE CORPORATION 2023-01-05 US disclosed
WO-2022261159-A1 TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS INCYTE CORPORATION (US) 2022-12-15 WO disclosed
US-10681909-B2 Herbicidal triazoles FMC CORPORATION (US) 2020-06-16 US disclosed
US-20170354149-A1 HERBICIDAL TRIAZOLES FMC CORPORATION 2017-12-14 US disclosed
EP-3185684-A1 HERBICIDAL TRIAZOLES E. I. du Pont de Nemours and Company (US) 2017-07-05 EP disclosed
US-9695154-B2 Heteroaryl inhibitors of sumo activating enzyme MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-07-04 US disclosed
US-9695154-B2 Heteroaryl inhibitors of sumo activating enzyme MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-07-04 US disclosed
CN-106659159-A Herbicidal triazoles 杜邦公司 2017-05-10 CN disclosed
US-20160355504-A1 HETEROARYL INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-12-08 US disclosed
US-20160355504-A1 HETEROARYL INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-12-08 US disclosed
WO-2016033285-A1 HERBICIDAL TRIAZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2016-03-03 WO disclosed
US-20150105252-A1 SUBSTITUTED PYRAZOLES AS HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY 2015-04-16 US disclosed
WO-2015002994-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170354149-A1 HERBICIDAL TRIAZOLES CYP1A1, CYP1B1, CYP4X1 LOXL2 1812/4885LOX 905/4885KCNQ2 2496/4885
US-12428420-B2 Tricyclic heterocycles as FGFR inhibitors FGFR3, FGFR1, FGFR2 LOXL2 2606/4885LOX 2737/4885KCNQ2 4255/4885
US-10681909-B2 Herbicidal triazoles CYP1A1, CYP1B1, CYP4X1 LOXL2 1812/4885LOX 905/4885KCNQ2 2496/4885
US-20160355504-A1 HETEROARYL INHIBITORS OF SUMO ACTIVATING ENZYME SAE1, SUMO2, SUMO1 LOXL2 2836/4885LOX 2724/4885KCNQ2 3690/4885
US-20150105252-A1 SUBSTITUTED PYRAZOLES AS HERBICIDES CYP1B1, CYP1A1, DDT LOXL2 2787/4885LOX 986/4885KCNQ2 725/4885
US-20230002384-A1 TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS FGFR3, FGFR1, FGFR2 LOXL2 2606/4885LOX 2737/4885KCNQ2 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.